5-methylcytosine has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, T; Zhou, HF | 1 |
| Bondue, B; Chavez, V; Corhay, JL; Guiot, J; Hardat, N; Henket, M; Herzog, M; Louis, R; Moermans, C; Scoubeau, K; Struman, I | 1 |
2 other study(ies) available for 5-methylcytosine and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis.
Topics: 5-Methylcytosine; Biomarkers; Humans; Idiopathic Pulmonary Fibrosis; Prognosis; Reproducibility of Results | 2022 |
Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Biomarkers; DNA Methylation; Epigenesis, Genetic; Female; Histones; HMGB1 Protein; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Nucleosomes | 2017 |